Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.
Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C. Seror R, et al. Among authors: carsons s. RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. RMD Open. 2015. PMID: 26509054 Free PMC article. Review.
Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index.
Seror R, Mariette X, Bowman S, Baron G, Gottenberg JE, Bootsma H, Theander E, Tzioufas A, Vitali C, Ravaud P; European League Against Rheumatism Sjögren's Task Force. Seror R, et al. Arthritis Care Res (Hoboken). 2010 Apr;62(4):551-8. doi: 10.1002/acr.20173. Arthritis Care Res (Hoboken). 2010. PMID: 20391511 Free article.
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.
Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ; EULAR Sjögren's Task Force. Seror R, et al. Among authors: carsons s. Ann Rheum Dis. 2011 Jun;70(6):968-72. doi: 10.1136/ard.2010.143743. Epub 2011 Feb 22. Ann Rheum Dis. 2011. PMID: 21345815
New Treatment Guidelines for Sjögren's Disease.
Vivino FB, Carsons SE, Foulks G, Daniels TE, Parke A, Brennan MT, Forstot SL, Scofield RH, Hammitt KM. Vivino FB, et al. Among authors: carsons se. Rheum Dis Clin North Am. 2016 Aug;42(3):531-51. doi: 10.1016/j.rdc.2016.03.010. Rheum Dis Clin North Am. 2016. PMID: 27431353 Free PMC article. Review.
Treatment of primary Sjögren syndrome with rituximab.
Faustman DL, Vivino FB, Carsons SE. Faustman DL, et al. Ann Intern Med. 2014 Sep 2;161(5):376-7. doi: 10.7326/L14-5017-3. Ann Intern Med. 2014. PMID: 25178574 No abstract available.
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.
Hernández-Molina G, Kostov B, Brito-Zerón P, Vissink A, Mandl T, Hinrichs AC, Quartuccio L, Baldini C, Seror R, Szántó A, Isenberg D, Gerli R, Nordmark G, Rasmussen A, Solans-Laque R, Hofauer B, Sène D, Pasoto SG, Rischmueller M, Praprotnik S, Gheita TA, Danda D, Armağan B, Suzuki Y, Valim V, Devauchelle-Pensec V, Retamozo S, Kvarnstrom M, Sebastian A, Atzeni F, Giacomelli R, Carsons SE, Kwok SK, Nakamura H, Fernandes Moça Trevisani V, Flores-Chávez A, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium. Hernández-Molina G, et al. Among authors: carsons se. Rheumatology (Oxford). 2022 Dec 23;62(1):243-255. doi: 10.1093/rheumatology/keac205. Rheumatology (Oxford). 2022. PMID: 35385104
Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain.
Carsons SE, Vivino FB, Parke A, Carteron N, Sankar V, Brasington R, Brennan MT, Ehlers W, Fox R, Scofield H, Hammitt KM, Birnbaum J, Kassan S, Mandel S. Carsons SE, et al. Arthritis Care Res (Hoboken). 2017 Apr;69(4):517-527. doi: 10.1002/acr.22968. Epub 2017 Mar 3. Arthritis Care Res (Hoboken). 2017. PMID: 27390247 Review.
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren's Syndrome. Vitali C, et al. Among authors: carsons se. Ann Rheum Dis. 2002 Jun;61(6):554-8. doi: 10.1136/ard.61.6.554. Ann Rheum Dis. 2002. PMID: 12006334 Free PMC article. Review.
Extraglandular manifestations of primary Sjögren's syndrome.
Ienopoli S, Carsons SE. Ienopoli S, et al. Among authors: carsons se. Oral Maxillofac Surg Clin North Am. 2014 Feb;26(1):91-9. doi: 10.1016/j.coms.2013.09.008. Oral Maxillofac Surg Clin North Am. 2014. PMID: 24287197 Review.
115 results